N4 Pharma Plc (FRA:0GO)
0.0010
0.00 (0.00%)
At close: Jan 23, 2026
N4 Pharma Revenue
N4 Pharma had revenue of 3.69K GBP in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 7.07K, up 20.60% year-over-year. In the year 2024, N4 Pharma had annual revenue of 7.28K with 272.86% growth.
Revenue (ttm)
7.07K GBP
Revenue Growth
+20.60%
P/S Ratio
553.81
Revenue / Employee
1.77K GBP
Employees
4
Market Cap
4.57M EUR
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.28K | 5.33K | 272.86% |
| Dec 31, 2023 | 1.95K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| sdm SE | 40.03M |
| Brüder Mannesmann Aktiengesellschaft | 24.23M |
| Spielvereinigung Unterhaching Fußball GmbH & Co. KGaA | 11.29M |
| Pittler Maschinenfabrik AG | 10.45M |
| ZhongDe Waste Technology AG | 8.05M |
| BigRep SE | 7.92M |
| H2 Core AG | 1.02M |
| Finchain Capital Partners AG | 45.12K |